Provided by Tiger Fintech (Singapore) Pte. Ltd.

Imunon, Inc.

1.91
-0.6000-23.90%
Pre-market: 1.88-0.0340-1.78%08:35 EDT
Volume:8.60M
Turnover:19.87M
Market Cap:38.81M
PE:-1.37
High:2.74
Open:2.40
Low:1.91
Close:2.51
Loading ...

Imunon Inc. Presents Updated Survival Analysis from OVATION-2 Trial on Safety and Efficacy of IMNN-001 in Advanced EOC Patients

Reuters
·
Yesterday

Imunon announces data from Phase 2 OVATION 2 study on IMNN-001

TIPRANKS
·
Yesterday

Imunon Announces Data Presented at Asco Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study

THOMSON REUTERS
·
Yesterday

Imunon files to sell 22.03M shares of common stock for holders

TIPRANKS
·
31 May

Imunon Inc. Faces Nasdaq Delisting After Failing to Meet Minimum Bid Price Requirement

Reuters
·
31 May

Imunon Closes Private Placement of Shares, Warrants to Raise Up to $9.75 Million

MT Newswires Live
·
29 May

Imunon Closes up to $9.75 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
29 May

Imunon Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at Esmo Gynaecological Cancers Congress 2025

THOMSON REUTERS
·
27 May

Imunon announces up to $9.75M private placement priced at-the-market

TIPRANKS
·
26 May

Imunon Announces up to $9.75 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
24 May

IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswire
·
24 May

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires Live
·
24 May

Sector Update: Health Care Stocks Softer Friday Afternoon

MT Newswires Live
·
24 May

Top Midday Gainers

MT Newswires Live
·
24 May

Nasdaq Down Over 1%; Workday Shares Tumble After Q1 Results

Benzinga
·
23 May

Imunon Stock (IMNN) Rockets on Clinical Trial Results

TIPRANKS
·
23 May

Imunon Reports Prolonged Survival in Study of Potential Ovarian Cancer Treatment; Shares Soar Pre-Bell

MT Newswires Live
·
23 May

Imunon announces data from Phase 2 OVATION 2 study on IMNN-001

TIPRANKS
·
23 May

Imunon announces withdrawal of Form S-1 Registration Statement

TIPRANKS
·
23 May

Imunon Announces Withdrawal of Form S-1 Registration Statement

THOMSON REUTERS
·
23 May